USBC, Inc. — Director's Dealing 2019

Dec 23, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KNOW LABS, INC. (KNWN)
CIK: 0001074828
Period of Report: 2019-12-19

Reporting Person: Bosua Phillip (Director, CEO and President, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-04	Option to Purchase Common Stock	$1.10	A	1200000	Acquired	2024-11-04	Common Stock (1200000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2855000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Stock	$1.28	2023-08-01	Common Stock (1000000)	1000000	Direct

Footnotes

F1: Option shares vest 25% quarterly over four years beginning 08/01/2018.

F2: Option shares vest upon approval of the Company's blood glucose measurement technology by the U.S. Food and Drug Administration.